NEWSROOM

Stox Media – Wall Street Nation

PRISM AdTech & Media Company Spotlight: Creative Realities Illuminates the Future of Experiential Design

PRISM AdTech & Media Company Spotlight: Creative Realities Illuminates the Future of Experiential Design

Dec 16, 2023

In the fast-paced landscape of experiential design and technology, Creative Realities Inc. seamlessly integrates the physical and digital realms in creating immersive experiences that captivate audiences across various industries. NEW YORK, NY, December 16, 2023 - Creative Realities specializes in interactive displays, immersive retail solutions, and cutting-edge content creation to reshape how individuals connect with brands and spaces. With a commitment to innovation and a client-centric...

Rogue One Provides Corporate Update

Rogue One Provides Corporate Update

Dec 15, 2023

WASHINGTON, DC, December 15, 2023 -As many are aware, Rogue One, Inc. ("Company") has not submitted any financial statements subsequent to the Quarterly Report dated September 30, 2021. It is imperative to note that the recent action undertaken by the Securities and Exchange Commission on December 5, 2023, was not involuntary, but a result of a negotiated ‘Stipulation Letter' with the SEC which leads to revoking our 12G securities registration status. Consequently, Rogue One, Inc is no longer...

PRISM MediaWire – Weekly Press Resume – Dec. 11 to Dec. 15, 2023

PRISM MediaWire – Weekly Press Resume – Dec. 11 to Dec. 15, 2023

Dec 15, 2023

New York, December 15, 2023 PRISM MediaWire - Weekly Press Resume Dec. 11 to Dec. 15, 2023 UAT Group Receives Financing for Iron Removal System https://prismmediawire.com/uat-group-receives-financing-for-iron-removal-system/ SKYX and GE Sign a Five-Year Renewal of a Global Licensing Master Service Agreement as SKYX Continues to Enhance its Market Penetration and Collaborations with U.S. and World Leading Strategic Companies...

“Exceptional Result”: NeuroSense Therapeutics Reports New Positive Data from ALS Trial

“Exceptional Result”: NeuroSense Therapeutics Reports New Positive Data from ALS Trial

Dec 15, 2023

NEW YORK, NY, December 15, 2023 - NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) has reported additional positive efficacy data from its Phase 2b trial evaluating PrimeC, the company’s lead drug candidate for amyotrophic lateral sclerosis (ALS). The company’s share price rose nearly 30% in trading on Thursday. https://prismmarketview.com/companies/neurosense-therapeutics-ltd/ Alon Ben-Noon, NeuroSense’s CEO, commented, “As we analyze the PARADIGM trial results, we continue to gain a better...

CORRECTION FROM SOURCE: SinglePoint, Inc. – The Inaugural US Company to List on Cboe BZX Exchange

Dec 15, 2023

Correcting number of shares in previous Press Release SinglePoint, Inc. common stock to begin trading on Cboe BZX Exchange on December 15th, 2023, under the symbol “SING” Simultaneous capital raise of $4 Million Enable the Company to fully execute its national acquisition strategy and expand solar, battery, EV charging businesses Phoenix, AZ, December 15, 2023 - SinglePoint, Inc. (Cboe BZX: SING) ("SinglePoint" or "the Company"), a renewable solar energy and sustainable solutions provider,...

SinglePoint, Inc.–The Inaugural US Company to List on Cboe BZX Exchange

Dec 15, 2023

SinglePoint, Inc. common stock to begin trading on Cboe BZX Exchange on December 15th, 2023, under the symbol “SING” Simultaneous capital raise of $4 Million Enable the Company to fully execute its national acquisition strategy and expand solar, battery, EV charging businesses Phoenix, AZ, December 15, 2023 - SinglePoint, Inc. (Cboe BZX: SING) ("SinglePoint" or "the Company"), a renewable solar energy and sustainable solutions provider, announced today that its shares of common stock to begin...

Verde Bio Holdings Announces Entry Into Business Combination Agreement with SensaSure Technologies, Inc.

Dec 15, 2023

Transaction will provide Formation Minerals Inc., a wholly-owned subsidiary of SensaSure Technologies, Inc. (OTCQB: SSTC) the ability to be one of the first end to end platforms to build, run, manage, grow and monetize oil and gas mineral and royalty portfolios LAS VEGAS, NV and JACKSBORO, TX, December 15, 2023 – Verde Bio Holdings, Inc. (OTC: VBHI) (“Verde”), an emerging oil and gas royalty company, and SensaSure Technologies, Inc. (OTCQB: SSTC) (“SSTC”) today announced that Verde has entered...

SinglePoint Announces Pricing of $4 Million Public Offering, Uplisting to Cboe Global Markets and Reverse Stock Split

Dec 15, 2023

Phoenix, AZ, December 15, 2023 - SinglePoint Inc. formerly (OTC: SING) now trades as (Cboe: SING) (“SinglePoint” or the “Company”), a diversified holding company principally engaged through its subsidiaries in providing renewable energy solutions and energy-efficient applications to drive better health and living, today announced the pricing of its underwritten public offering of 800,000 shares of common stock at a public offering price of $5.00 per share. The gross proceeds from the...

PRISM AdTech & Media Company Spotlight: Creative Realities Illuminates the Future of Experiential Design

PRISM AdTech & Media Company Spotlight: Creative Realities (CREX) Illuminates the Future of Experiential Design

Dec 14, 2023

NEW YORK, NY, December 14, 2023 - In the fast-paced landscape of experiential design and technology, Creative Realities Inc. ($CREX) seamlessly integrates the physical and digital realms in creating immersive experiences that captivate audiences across various industries. From transforming retail spaces into dynamic environments to utilizing cutting-edge technologies in interactive displays, CREX is reshaping the way we interact with the world....

Center for Medicare Services Established National Pricing of AmnioWrap2 (TM) in All MAC Regions

Dec 14, 2023

Pricing Provides AmnioWrap2TM Reimbursement in All MAC Regions POMPANO BEACH, FLORIDA, December 14, 2023 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, announced that the Center for Medicare Services (CMS) has established national pricing for its product, AmnioWrap2TM, in all Medicare Administrative Contractors (MAC) regions. This pricing...

Sono-Tek Announces Preliminary Record Revenue with Continued Strong Backlog for Q3 FY2024 and Increases Revenue Guidance for Fiscal Year 2024

Sono-Tek Announces Preliminary Record Revenue with Continued Strong Backlog for Q3 FY2024 and Increases Revenue Guidance for Fiscal Year 2024

Dec 14, 2023

- Sales Grew 58% YOY; Backlog Grew 68% YOY and Remains Strong at $10.4 Million; Company Projects 30% Revenue Growth for Fiscal Year ending February 29, 2024- MILTON, NY, December 14, 2023 – Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced preliminary sales and backlog for the third quarter of fiscal year 2024, ended November 30, 2023. • Preliminary sales for the third quarter of FY2024 were...

PRISM Oil & Gas: S&P Sets Fresh YTD High; Falling Gasoline Prices Play Key Role in Cooling Inflation

PRISM Oil & Gas: S&P Sets Fresh YTD High; Falling Gasoline Prices Play Key Role in Cooling Inflation

Dec 13, 2023

NEW YORK, NY, December 13, 2023 - US equities closed mostly higher on Tuesday as the S&P set a fresh year-to-date high, finishing the day at its highest level since January 2022, just 3.2% below its all-time high. Energy stocks underperformed while gasoline prices were down (6%) for the month, playing a key role in cooling inflation numbers for November. The S&P 500 Energy Index was down (1.35%) versus the S&P 500 which rose +0.14%. The XLE settled down (1.39%), the XOP fell...

FDA Grants PMA Supplement Approval for ReShape Lifesciences Lap Band; Shares Surge 100%

FDA Grants PMA Supplement Approval for ReShape Lifesciences Lap Band; Shares Surge 100%

Dec 13, 2023

NEW YORK, NY, December 13, 2023 - ReShape Lifesciences (Nasdaq: RSLS) has been granted FDA approval of a PMA supplement for the company’s next generation, enhanced Lap-Band® 2.0 FLEX. The company’s share price surged 100% in trading on Wednesday morning. https://prismmarketview.com/companies/reshape-lifesciences-inc/ Paul F. Hickey, President and Chief Executive Officer of ReShape Lifesciences, said, “PMA supplement approval for our next generation Lap-Band® 2.0 FLEX is a...

PRISM MarketView Biotech in Motion Spotlight: Quoin Receives FDA Clearance for Netherton Syndrome Clinical Optimization Plan

PRISM MarketView Biotech in Motion Spotlight: Quoin Receives FDA Clearance for Netherton Syndrome Clinical Optimization Plan

Dec 13, 2023

NEW YORK, NY, December 13, 2023 - Quoin Pharmaceuticals (Nasdaq: QNRX) has received U.S. Food and Drug Administration (FDA) clearance to implement several protocol amendments to its two ongoing clinical trials for QRX003, which is a potential treatment for Netherton Syndrome, a rare genetic skin disease for which there is no cure and no approved treatments. These protocol amendments are being implemented with a view to generating an even more robust data set and potentially more...

BioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors

Dec 13, 2023

POMPANO BEACH, FLORIDA, December 13, 2023 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces the appointment of Mr. Thomas J. Dugan to the position of Chairman of the Board. Mr. Dugan brings a wealth of experience to BioStem, with proven, hands-on expertise as a senior executive who has transformed businesses, established new...

GK Financing LLC, a Subsidiary of American Shared Hospital Services, Announces Agreement to Reload Lovelace Medical Center with New Cobalt Sources and Software Upgrade

Dec 13, 2023

Installation expected to be Completed in Mid-2024 SAN FRANCISCO, December 13, 2023 - GK Financing LLC (GKF), a subsidiary of American Shared Hospital Services (NYSE American: AMS), a leading provider of creative financial and turnkey technology solutions for advanced radiosurgery and radiation oncology services, announced today that it has entered into an agreement with Lovelace Medical Center (LMC), Albuquerque, NM, to reload its Gamma Knife Icon with new Cobalt Sources, as well as install...

PRISM NEXT GEN TECH COMPANY SPOTLIGHT: THE GLIMPSE GROUP’S JOURNEY INTO THE FUTURE

Dec 12, 2023

NEW YORK, NY, December 12, 2023 - An immersive technology platform company, Glimpse recently announced its plans for a strategic shift from current immersive technologies that include virtual-reality headsets, tablets and phones to spatial computing, cloud and AI-driven immersive software solutions. From cutting-edge software development to immersive content creation, Glimpse pushes the boundaries of what is possible in the realm of extended realities....

PRISM MarketView Launches Emerging AdTech and Media Index

Dec 12, 2023

Leading global companies work to strike balance between digital and traditional advertising Industry experts point to 2H 2024 for AdTech and Media IPO market to strengthen NEW YORK, NY, December 12, 2023 - PRISM MarketView, a leading provider of unbiased market insight and company news, today announces the launch of its PRISM Emerging AdTech and Media Index. With a finger on the pulse of the digital media revolution, the PRISM index is tracking emerging companies making a mark on the adtech...

Metatron Pioneers AI-driven Content Discovery and issues Reverse Split Moratorium

Metatron Pioneers AI-driven Content Discovery and issues Reverse Split Moratorium

Dec 12, 2023

Dover, DE, December 12, 2023 - Metatron Apps Inc. (OTC: MRNJ), a prominent figure in the digital technology sector with a portfolio boasting over 1000 mobile applications, is thrilled to announce the upcoming launch of Fanfinder.ai, its innovative AI-driven discovery tool. Tailored for platforms such as OnlyFans and TikTok, this app marks a significant advancement in Metatron’s suite of AI offerings, highlighting the company’s commitment to reshaping the digital content landscape. Notably,...

INTK Announces Senior Management Changes; Substantial Share Retirement And Cancels Reverse Split

INTK Announces Senior Management Changes; Substantial Share Retirement And Cancels Reverse Split

Dec 12, 2023

Naples, FL, December 12, 2023 - Industrial Nanotech Inc. (OTC: INTK) today announced that Stuart Burchill, the group's founding Chairman and Chief Executive Officer has decided to step down from his roles effective December 12, 2023, for health reasons. Craig Fischer will take over effective immediately as CEO of the Company and its subsidiaries, Syneffex, TalkingPaint, and Anaconda Insulation. Mr. Fischer will be joined by Jaime (Jay) Cruz, the former President of the Company, as...

Hand-Spun Success: Why Did Shake Shack’s Shares Jump Today?

Hand-Spun Success: Why Did Shake Shack’s Shares Jump Today?

Dec 11, 2023

NEW YORK, NY, December 11, 2023 - Shares in the casual dining chain, Shake Shack ($SHAK) jumped nearly 10% today after the company provided a financial outlook for 2024 and announced the departure of its long-time CEO, Randy Garutti. Mr. Garutti will continue to lead Shake Shack as CEO and as an executive Board member until early 2024. The company stated it would retain Mr. Garutti as an advisor through the end of 2024 to ensure a seamless transition....

MyMD Tackles Rheumatoid Arthritis with Launch of Phase 2 Trial in Early 2024

MyMD Tackles Rheumatoid Arthritis with Launch of Phase 2 Trial in Early 2024

Dec 11, 2023

NEW YORK, NY, December 11, 2023 - The FDA has cleared an Investigational New Drug Application (IND) for MyMD Pharmaceuticals (Nasdaq: MYMD) to initiate a Phase 2 clinical trial of oral MYMD-1® as a treatment for rheumatoid arthritis (RA). The company plans to launch the trial in the first quarter of 2024. Chris Chapman, M.D., president, director, and chief medical officer of MyMD Pharmaceuticals, said, “With the FDA’s recent clearance of our IND in RA, we are moving forward with plans to...

SKYX and GE Sign a Five-Year Renewal of a Global Licensing Master Service Agreement as SKYX Continues to Enhance its Market Penetration and Collaborations with U.S. and World Leading Strategic Companies

Dec 11, 2023

MIAMI, FL, December 11, 2023 - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the "Company" or "SKYX"), a highly disruptive platform technology company with 77 pending and issued patents globally and over 60 lighting and home décor websites, with a mission to make homes and buildings become safe and smart as the new standard, today announced that it has signed with GE Technology Development, Inc. ("GE") a five-year renewal of a global licensing master service agreement to...

UAT Group Receives Financing for Iron Removal System

Dec 11, 2023

TAMPA, FL, December 11, 2023 - Umbra Applied Technologies Group, Inc (OTC PINK: UATG), announced today that it has reached an agreement with a lending partner to support the growth of its subsidiary H2O Processing. The private equity partner has provided the necessary strategic growth capital to support the production of its iron mitigation systems that remove metal ion from crude oil. Initial systems have entered production and are expected to be delivered to customer sites over the next...

PRISM MediaWire – Weekly Press Resume – Dec. 04 to Dec. 08, 2023

PRISM MediaWire – Weekly Press Resume – Dec. 04 to Dec. 08, 2023

Dec 8, 2023

New York, December 08 , 2023 PRISM MediaWire - Weekly Press Resume Dec 04 to Dec. 08, 2023 Xcyte Digital Produces Second Metaverse Spectrum Business Conference and Launches Inaugural Pitch Fest https://prismmediawire.com/xcyte-digital-produces-second-metaverse-spectrum-business-conference-and-launches-inaugural-pitch-fest/ Peer To Peer Network Announces It Has Hired A PR Firm. Set To Start Major Public Relations Operation Starting In 2024...

FREEDOM HOLDINGS (FHLD) SHAREHOLDER UPDATE; 15c211 nears final approval from FINRA

Dec 8, 2023

Chatsworth, CA, December 08, 2023 - Freedom Holdings, Inc. aka Freedom Acquisition Corp (OTC: FHLD) ("FHLD" or the "Company") is pleased to announce following Company Update: Freedom Holdings waiting on 15c211 final approval from FINRA. This past summer Freedom Holdings retain Glendale securities to file it’s 15C-211 with FINRA. After answering all FINRA’s comments, Freedom Holdings nears final approval of its 15C-211 to bring company from current audited fully reporting Pink Sheet, to...

PRISM Analysis: Stocks Making the Biggest Moves in Thursday Trading

Dec 7, 2023

NEW YORK, NY, December 07, 2023 - US equities are settling mostly higher in Thursday midday trading, with big tech broadly higher as Google ($GOOG) rallies after the company’s launch of Project Gemini, an AI model trained to behave in human-like ways. Airlines, including JetBlue ($JBLU), credit cards and chemicals are performing well. https://prismmarketview.com/prism-analysis-stocks-making-the-biggest-moves-in-thursday-trading/ Notable gainers for the day include Verint Systems ($VRNT) which...

PRISM Next Gen Tech Company Spotlight: The Glimpse Group’s Journey into the Future

Dec 7, 2023

NEW YORK, NY, December 07, 2023 - In the ever-evolving landscape of technological innovation, the Glimpse Group, Inc. (VRAR) emerges as a beacon of creativity and ingenuity, weaving a future where virtual and augmented realities seamlessly blend with our daily lives. Glimpse, combines reality with the extraordinary, allowing for the future to become a tangible reality. https://prismmarketview.com/companies/the-glimpse-group/ Company Snapshot: A Glimpse into Glimpse Group At the heart of...

PRISM MarketView Biotech Index Top Mover Spotlight: Kamada (KMDA)

Dec 7, 2023

NEW YORK, NY, December 07, 2023 - PRISM MarketView, a leading provider of unbiased market insight and company news, highlights Kamada Ltd. (Nasdaq: KMDA), a commercial-stage global biopharmaceutical company with a portfolio of products for rare and serious conditions and a leader in the specialty plasma-derived field, today announced it has inked its largest commercial agreement to date, set to take effect in January 2024. https://prismmarketview.com/companies/kamada-ltd/...

Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays

Dec 6, 2023

Significant unmet need for regulated product in $2B US testing market Opportunity for expedited pathway for kitted product in development IRVINE, CA, December 06, 2023 - Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today announced it has begun the FDA single-site process for its VitaGraft transplant assays. The single-site process is a well-established pathway for Lab Developed Tests (LDTs) to seek regulatory approval. This move positions Oncocyte within the recent...